Insmed | INSM

Aktienkurs
128.88
Täglich Wechseln
-3.67 -2.77%
Monatlich
10.60%
Jährlich
17.64%
Q3 Prognose
96.51

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-22 FY2026Q3 AM -0.61 -1.75
2026-08-06 FY2026Q2 AM -0.06 -0.75 -1.70
2026-05-07 FY2026Q1 AM -0.76 -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 62.92 1.46 2.38% 9.75% 2026-08-07
Cytokinetics 76.51 -4.86 -5.97% 124.30% 2026-08-07
DBV Technologies 13.53 -0.21 -1.53% 38.46% 2026-08-07
Gilead Sciences 133.62 2.76 2.11% 11.90% 2026-08-07
Heron Therapeutics 0.49 -0.01 -2.10% -62.99% 2026-08-07
Insmed 128.88 -3.67 -2.77% 17.64% 2026-08-07
Novartis 154.21 -0.23 -0.15% 30.88% 2026-08-06
Ultragenyx Pharmaceutical 25.42 -0.40 -1.55% -8.66% 2026-08-07
Regeneron Pharmaceuticals 782.89 10.78 1.40% 39.06% 2026-08-07
Sarepta Therapeutics 16.57 -0.22 -1.28% -7.77% 2026-08-07

Preis Tag Jahr Datum
USND 26610 261.72 0.99% 24.06% 2026-08-07
US2000 3031 29.59 0.99% 36.64% 2026-08-07